Cedars-Sinai Licenses Brain Vaccine Tech to Pasadena-Based StemVax

Cedars-Sinai Medical Center has awarded rights to a preclinical vaccine to prevent recurring brain tumors to StemVax Therapeutics, an emerging biotechnology firm based in Pasadena.